RNAZ TRANSCODE THERAPEUTICS INC Delisting Actions 8-K Filing 2023 - Delisting Transcode Therapeutics, Inc. received a deficiency letter from Nasdaq stating that it is not in compliance with the minimum stockholders equity requirement for continued listing on the Nasdaq Capital Market.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC